Results 241 to 250 of about 136,204 (260)

Selective inhibition of the NLRP3 inflammasome by targeting to promyelocytic leukemia protein in mouse and human.

Blood, 2013
Yu-Hsun Lo, Yu-Wen Huang, Yung-Hsuan Wu, Chi-Shan Tsai, Yu-Chuan Lin, Shu-Ting Mo, W. Kuo, Ya-Ting Chuang, Si‐Tse Jiang, H. Shih, M. Lai   +10 more
semanticscholar   +1 more source

Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review

Ca-A Cancer Journal for Clinicians, 2023
Allison J L'hotta
exaly  

PROTAC targeted protein degraders: the past is prologue

Nature Reviews Drug Discovery, 2022
Miklos Bekes, David R Langley, Craig M Crews   +2 more
exaly  

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Carol E Desantis, James R Cerhan   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Current recommendations and recent progress in endometrial cancer

Ca-A Cancer Journal for Clinicians, 2019
Gini F Fleming
exaly  

MicroRNAome genome: A treasure for cancer diagnosis and therapy

Ca-A Cancer Journal for Clinicians, 2014
Ioana Berindan-Neagoe, Barbara Pasculli, George A Calin   +2 more
exaly  

Increased cancer burden among pesticide applicators and others due to pesticide exposure

Ca-A Cancer Journal for Clinicians, 2013
Matthew R Bonner
exaly  

Promyelocytic leukemia protein

, 2012
K. Borden, B. Culjkovic-Kraljacic
semanticscholar   +1 more source

Hypercalcemia and cancer: Differential diagnosis and treatment

Ca-A Cancer Journal for Clinicians, 2018
Sarah B Fisher
exaly